The AMaRC Data and Safety Monitoring Committee met on Aug 26th to review the safety run-in component of the BelaCarD study. The DSMC assessed the safety data and determined that the trial can move to the phase II component, expanding the trial to more patients.

The following sites are now opened to recruitment:

• Flinders Medical Centre
• Royal Adelaide Hospital